Xolatryp
Cardioprotection (STEMI) and Neuroprotection (stroke, TBI)
Phase 1Active
Key Facts
Indication
Cardioprotection (STEMI) and Neuroprotection (stroke, TBI)
Phase
Phase 1
Status
Active
Company
About Nyrada
Australian‑listed biotech advancing TRPC‑channel inhibitors for cardiovascular and neurological unmet needs.
View full company profile